← Open Payments lookup

ETHEL AKONGNUI: Open Payments

NPI 1174396923 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$868 in 39 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $881 · 2025 $868

Food & beverage: $868
CompanyPaymentsAmount
ABBVIE INC.8$211
Alkermes, Inc.9$139
Otsuka America Pharmaceutical, Inc.4$93
E.R. Squibb & Sons, L.L.C.1$88
Vanda Pharmaceuticals Inc.3$74
Takeda Pharmaceuticals U.S.A., Inc.3$51
Neurocrine BioSciences, Inc.2$39
Axsome Therapeutics, Inc.2$37
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$33
Supernus Pharmaceuticals, Inc.2$32

Products named: VRAYLAR, ARISTADA, REXULTI, COBENFY, FANAPT, TRINTELLIX, INGREZZA, Auvelity.

Industry payments across KS — which companies pay providers there.